Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT00934349
Other study ID # 2009-A00348-49
Secondary ID CHR-GHSR_2009-03
Status Recruiting
Phase N/A
First received July 2, 2009
Last updated July 7, 2009
Start date June 2009

Study information

Verified date July 2009
Source Groupe Hospitalier Sud Reunion
Contact FRANCOISE DARCEL, PHD
Phone +262 262 359 166
Email francoise.darcel@chr-reunion.fr
Is FDA regulated No
Health authority France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study type Observational

Clinical Trial Summary

The purpose of this study is to assess the existence of a genetic factor, suspected to be involved, aside from likely food deficiency contribution, in occurrence of dry beriberi, in patients who experienced dry beriberi and in a case group composed of 3 people, free from beriberi, within the same household.


Description:

A team of 2 investigators, a nurse and an investigator speaking French, Shibushi and Shimaore (3 languages in use in Mayotte), will visit exposed patients who agreed to participate to the study.

3 controls, fulfilling inclusion criteria, will be recruited within the household by drawing lots.

Clinical examination and food survey by means of a questionnaire will be performed.

Blood samples will be drawn to determine thiamine status, vitamin B1 dosage, erythrocyte transketolase activity and thiamine pyrophosphate effect, analysis will be performed by Biomnis laboratory in Lyon.

For the genetic study, 4 drops of blood will be put down on Whatman paper and sent to Dr Johannes COY in Darmstadt Germany, for DNA extraction and PCR screening for mutations.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 15 Years and older
Eligibility Inclusion Criteria:

- patients

- Native to the Comoro Archipelago (Grande Comore, Mayotte, Anjouan, Mohéli)

- Fulfilling the clinical definition of the dry beriberi.

- Both sexes.

- Older than 15 years and 3 months (limit of the paediatrics).

- Having signed and whose legal representatives signed the form of assent, having understood the information.

- Benefiting from a social coverage regime.

- Controls

- Native to the Comoro Archipelago.

- People living in the same household as the patient, sharing the same meals.

- Both sexes.

- Older than 15 years old and 3 months.

- Free from beriberi.

- With normal neurological examination.

- Having signed and whose legal representatives signed the form of assent, having understood the information.

- Benefiting from a social coverage regime.

Exclusion Criteria:

- Aged under 15-year-old and 3 months.

- For the patients and the witnesses, the presence of pathologies known to increase needs in vitamin B1 (cancer, infectious diseases, fever, hyperthyroïdism, chronic alcoholism).

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
France Central Hospital - MAYOTTE Mamudzu

Sponsors (1)

Lead Sponsor Collaborator
Groupe Hospitalier Sud Reunion

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mutations on one of the alleles of the promoter of the gene TKTL1 (transketolase-like gene) in the homozygous state in the patients and not in the controls (heterozygotes or not carrier of the mutation). day 1 No
Secondary To evaluate food intakes in vitamin B1 and anti-thiamine factors (polyphenols). day 1 No
Secondary To evaluate Thiamine biological status (blood thiamine, erythrocyte transketolase activity and the thiamine pyrophosphate effect) day 1 No
See also
  Status Clinical Trial Phase
Completed NCT04977557 - Thiamine in Patients With Clinically Suspected Dry Beriberi N/A